ACE and breast cancer: These evaluations enable the cardio-oncology team to provide breast cancer patients with timely and optimal prevention methods utilizing various cardioprotective agents, such as beta blockers, statins, aldosterone antagonists, ACE inhibitors, dexrazoxane, etc. [22,23,24,25].